Recombinant adenovirus vaccine encoding a chimeric T-cell antigen receptor induces protective immunity against a T-cell lymphoma.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cancer Research

• Publication date

  2000-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10825142
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TCR vaccines against T cell lymphoma: QS-21 and IL-12 adjuvants induce a protective CD8+ T cell response.

  1999cited by this paper
• Murine dendritic cells transduced with an adenoviral vector expressing a defined tumor antigen can overcome anti-adenovirus neutralizing immunity and induce effective tumor regression.

  1999cited by this paper
• DNA vaccination against the idiotype of a murine B cell lymphoma: mechanism of tumor protection.

  1999cited by this paper
• Cancer statistics, 1999

  1999cited by this paper
• Impact of Preexisting and Induced Humoral and Cellular Immune Responses in an Adenovirus-Based Gene Therapy Phase I Clinical Trial for Localized Mesothelioma

  1998cited by this paper
• Adenovirus-mediated expression of melanoma antigen gp75 as immunotherapy for metastatic melanoma

  1998cited by this paper
• Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens.

  1998cited by this paper
• A simplified system for generating recombinant adenoviruses.

  1998cited by this paper
• QS-21 and QS-7: purified saponin adjuvants.

  1998cited by this paper
• DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma

  1998cited by this paper
• Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells.

  1997cited by this paper
• Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial.

  1997cited by this paper
• Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression

  1997cited by this paper
• Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response.

  1997cited by this paper
• Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination

  1997cited by this paper
• Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL.

  1997cited by this paper
• DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C.

  1997cited by this paper
• Dendritic Cells Transduced with an Adenoviral Vector Encoding a Model Tumor-Associated Antigen for Tumor Vaccination

  1997cited by this paper
• Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products.

  1997cited by this paper
• Circumvention of Anti-Adenovirus Neutralizing Immunity by Administration of an Adenoviral Vector of an Alternate Serotype

  1997cited by this paper
• TCR vaccines for active immunotherapy of T cell malignancies.

  1997cited by this paper
• Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli

  1996influential reference
• Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

  1996cited by this paper
• Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen.

  1996cited by this paper
• Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.

  1996cited by this paper
• Induction of a cytolytic T‐cell response in mice with a recombinant adenovirus coding for tumor antigen P815A

  1996cited by this paper
• Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

  1995cited by this paper
• Methods for construction of adenovirus vectors

  1995cited by this paper
• Long‐term humoral and cellular immunity induced by a single immunization with replication‐defective adenovirus recombinant vector

  1995cited by this paper
• Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma

  1993cited by this paper
• Gene therapy: adenovirus vectors.

  1993cited by this paper
• Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity.

  1990cited by this paper
• Expression of T cell antigen receptor heterodimers in a lipid-linked form.

  1990cited by this paper
• Prospects for the treatment of B cell tumors using idiotypic vaccination.

  1989cited by this paper
• Idiotypic vaccination as a treatment for a B cell lymphoma.

  1988cited by this paper
• Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA

  1988influential reference
• Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits.

  1987cited by this paper
• Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody.

  1982cited by this paper
• Cancer : Principles and Practice of Oncology

  1982cited by this paper
• [Chronic leukemias].

  1973cited by this paper

• The role of idiotype-specific immunity in antigen receptor diversity

  2010influential citation
• T lymphocyte responses against hepatitis B virus-related hepatocellular carcinoma induced by adenovirus vaccine encoding HBx.

  2010cites this paper
• Evaluation of NR2B peptide as subunit vaccines against experimental neuropathic pain.

  2007cites this paper
• Utility of Adenovirus-Based Vectors for Multiple Cancer Vaccine Approaches

  2004cites this paper
• Molecular rescue of tumour‐specific T cell receptor idiotype from T cell lymphomas

  2004cites this paper
• TCR Vaccines against a Murine T Cell Lymphoma: A Primary Role for Antibodies of the IgG2c Class in Tumor Protection1

  2004cites this paper
• cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing.

  2003cites this paper
• Definition of TCR Epitopes for CTL-Mediated Attack of Cutaneous T Cell Lymphoma 1

  2003cites this paper
• Lymphoma: A Primary Role for Antibodies TCR Vaccines against a Murine T Cell

  2003cites this paper
• Adenovirus and Adeno-Associated Virus Vectors

  2002cites this paper
• Vaccination therapy for cutaneous T‐cell lymphoma

  2002cites this paper
• Vaccines for Active Immunotherapy of T Cell Are More Effective Than TCR Id Protein Tumor Cell Lysate-Pulsed Dendritic Cells

  2002cites this paper
• In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphoma.

  2002cites this paper
• Tumor Cell Lysate-Pulsed Dendritic Cells Are More Effective Than TCR Id Protein Vaccines for Active Immunotherapy of T Cell Lymphoma1

  2002cites this paper
• Vaccination Strategies in the Treatment of Lymphomas

  2002cites this paper
• Vakzinationstherapie kutaner T-Zell-Lymphome

  2002cites this paper
• Dual TCR-Expressing T Lymphocytes in Health and Disease

  2001cites this paper
• Idiotype-encoding recombinant adenoviruses provide protective immunity against murine B-cell lymphomas.

  2001cites this paper
• IL-18 Gene Transfer by Adenovirus Prevents the Development of and Reverses Established Allergen-Induced Airway Hyperreactivity1

  2001cites this paper
• The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis.

  2001cites this paper
• T Cell Antigen Receptor Vaccines for Active Therapy of T Cell Malignancies

  2001cites this paper
• Allergen-Induced Airway Hyperreactivity the Development of and Reverses Established IL-18 Gene Transfer by Adenovirus Prevents

  2001cites this paper